EHA2026 Congress

Meet BIOTYPE at the EHA2026 Congress in Stockholm!

Next week we'll be at the EHA2026 Congress, where the global hematology community comes together to exchange what's new, what works, and what's next.

We're particularly excited to dive into sessions on molecular diagnostics and clinical innovation, and what they mean for leukemia stratification and patient monitoring in practice. It's exactly these discussions that drive us, most recently in the development of our Mentype^® AMLplus, which, together with the AMLplex^QS, forms a comprehensive AML panel covering both mutation and fusion gene screening for reliable stratification.

Let’s connect! Reach out to Marie Helbig at EHA2026 to schedule a meeting.